Industry

Foghorn cuts 40% of workforce after Lilly collaboration ends

Foghorn Therapeutics is laying off 40% of its workforce after Eli Lilly ended their drug development collaboration.

Reported by 2 outlets Thursday, October 1, 2026

The original reports on this story are listed below.

Reporting on this story

More top stories

This Week in Medicine

The week in medicine, in five minutes

The most important medical news of the week, summarized for you and easy to read. Every Sunday, free.

Free. No spam. Unsubscribe anytime.